Major adverse outcomes of non-haemorrhagic stroke, death and major bleeding do not differ between patients with asymptomatic or symptomatic atrial fibrillation (AF). The GARFIELD-AF study enrolled more than 52,000 patients of which 25% were asymptomatic and 75% had presented with symptoms such as palpitations or shortness of breath. The two groups had similar median CHA2DS2-VASc ...
Outcomes similar in silent or symptomatic AF
By Mardi Chapman
24 Feb 2021